PURPOSE: To provide population-based normative visual acuity (VA) by age, in children participating in the Sydney Paediatric Eye Disease Study aged 6 to <72 months. METHODS: Monocular VA was measured using the Amblyopia Treatment Study (ATS HOTV) protocol (24 to <72 months). Some children were also tested using linear ETDRS or HOTV logMAR VA charts (30 to <72 months). If unable to perform recognition acuity, the Teller Acuity Cards II (TAC II) was performed (6 to <42 months). Children with significant refractive error or ocular disease were excluded. RESULTS: Improvement in VA with age was shown on all three vision tests (all p < 0.0001). Mean VA using ATS HOTV (n = 836) was 0.13 logMAR (6/8) at <36 months, which improved to -0.01 (6/6) at 66 to <72 months. Mean ETDRS/HOTV (n = 399) VA was 0.26 logMAR (6/11) at <36 months, which improved to 0.1 (6/7.5) at 66 to <72 months. Mean monocular TAC II (n = 442) was 5.7 cycles/degree (0.72 logMAR) at 6 to <9 months and improved to 12.4 cycles/degree (0.38 logMAR) at age 30 to <33 months. Associations with ATS HOTV VA included prematurity (p = 0.027) and socio economic status (SES) factors such as home ownership (p = 0.039) and employment of one (p = 0.019) or both parents (p = 0.003). CONCLUSIONS: VA norms in children improved with age and were different according to the VA test used. Low SES was associated with poorer VA, supporting the need for test specific VA norms to be established for different populations. The ATS HOTV appears to be the best test to use for vision screening due to its lower false positive referral rate.
PURPOSE: To provide population-based normative visual acuity (VA) by age, in children participating in the Sydney Paediatric Eye Disease Study aged 6 to <72 months. METHODS: Monocular VA was measured using the Amblyopia Treatment Study (ATS HOTV) protocol (24 to <72 months). Some children were also tested using linear ETDRS or HOTV logMAR VA charts (30 to <72 months). If unable to perform recognition acuity, the Teller Acuity Cards II (TAC II) was performed (6 to <42 months). Children with significant refractive error or ocular disease were excluded. RESULTS: Improvement in VA with age was shown on all three vision tests (all p < 0.0001). Mean VA using ATS HOTV (n = 836) was 0.13 logMAR (6/8) at <36 months, which improved to -0.01 (6/6) at 66 to <72 months. Mean ETDRS/HOTV (n = 399) VA was 0.26 logMAR (6/11) at <36 months, which improved to 0.1 (6/7.5) at 66 to <72 months. Mean monocular TAC II (n = 442) was 5.7 cycles/degree (0.72 logMAR) at 6 to <9 months and improved to 12.4 cycles/degree (0.38 logMAR) at age 30 to <33 months. Associations with ATS HOTV VA included prematurity (p = 0.027) and socio economic status (SES) factors such as home ownership (p = 0.039) and employment of one (p = 0.019) or both parents (p = 0.003). CONCLUSIONS: VA norms in children improved with age and were different according to the VA test used. Low SES was associated with poorer VA, supporting the need for test specific VA norms to be established for different populations. The ATS HOTV appears to be the best test to use for vision screening due to its lower false positive referral rate.
Authors: Laura Liebermann; David A Leske; Sarah R Hatt; Yolanda S Castañeda; Suzanne M Wernimont; Christina S Cheng-Patel; Eileen E Birch; Jonathan M Holmes Journal: J AAPOS Date: 2017-05-17 Impact factor: 1.220
Authors: E Esteban-Ibañez; T Pérez-Roche; E Prieto; O Castillo; A Fanlo-Zarazaga; A Alejandre; D Gutierrez; M Ortin; V Pueyo Journal: Int Ophthalmol Date: 2021-10-07 Impact factor: 2.031
Authors: David A Leske; Sarah R Hatt; Yolanda S Castañeda; Suzanne M Wernimont; Laura Liebermann; Christina S Cheng-Patel; Eileen E Birch; Jonathan M Holmes Journal: Am J Ophthalmol Date: 2019-08-01 Impact factor: 5.258
Authors: Sarah R Hatt; David A Leske; Yolanda S Castañeda; Suzanne M Wernimont; Laura Liebermann; Christina S Cheng-Patel; Eileen E Birch; Jonathan M Holmes Journal: JAMA Ophthalmol Date: 2020-05-01 Impact factor: 7.389
Authors: Heather E Olson; Julia G Costantini; Lindsay C Swanson; Walter E Kaufmann; Timothy A Benke; Anne B Fulton; Ronald Hansen; Annapurna Poduri; Gena Heidary Journal: Dev Med Child Neurol Date: 2021-05-24 Impact factor: 5.449
Authors: Brian P Brooks; Wadih M Zein; Amy H Thompson; Maryam Mokhtarzadeh; Daniel A Doherty; Melissa Parisi; Ian A Glass; May C Malicdan; Thierry Vilboux; Meghana Vemulapalli; James C Mullikin; William A Gahl; Meral Gunay-Aygun Journal: Ophthalmology Date: 2018-07-25 Impact factor: 12.079
Authors: David A Leske; Sarah R Hatt; Yolanda S Castañeda; Suzanne M Wernimont; Christina S Cheng-Patel; Erick D Bothun; Eileen E Birch; Jonathan M Holmes Journal: J AAPOS Date: 2021-06-26 Impact factor: 1.325